Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy

Xavier M. Teitsma, Johannes W. G. Jacobs, Paco M. J. Welsing, Attila Pethö-schramm, Michelle E. A. Borm, Lidy Hendriks, Natasja H. A. M. Denissen, Jacob M. van Laar, Floris P. J. G. Lafeber, Johannes W. J. Bijlsma

doi:10.1093/rheumatology/kex319

DOI: 10.1093/rheumatology/kex319

,

PMID: 29029185

Issn Print: 1462-0324

Publication Date: 2017/12/01

Print

Xavier M. Teitsma; Johannes W. G. Jacobs; Paco M. J. Welsing; Attila Pethö-Schramm; Michelle E. A. Borm; Lidy Hendriks; Natasja H. A. M. Denissen; Jacob M. van Laar; Floris P. J. G. Lafeber; Johannes W. J. Bijlsma


		Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


		Loading Related Articles

Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy

Abstract

Related Topics